Related references
Note: Only part of the references are listed.Depression in Type 2 Diabetes Mellitus: Prevalence, Impact, and Treatment
Katherine Semenkovich et al.
DRUGS (2015)
Sex Differences in the Association Between Depression, Anxiety, and Type 2 Diabetes Mellitus
Ryan T. Demmer et al.
PSYCHOSOMATIC MEDICINE (2015)
Depression as a Risk Factor for Diabetes: A Meta-Analysis of Longitudinal Studies
Francesco Rotella et al.
JOURNAL OF CLINICAL PSYCHIATRY (2013)
Application of electronic medical record data for health outcomes research: a review of recent literature
Junji Lin et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2013)
A Review of the Association Between Depression and Insulin Resistance: Pitfalls of Secondary Analyses or a Promising New Approach to Prevention of Type 2 Diabetes?
Naomi Silva et al.
CURRENT PSYCHIATRY REPORTS (2012)
Increased Risk of Myocardial Infarction in Depressed Patients With Type 2 Diabetes
Jeffrey F. Scherrer et al.
DIABETES CARE (2011)
A Review of Treating Depression in Diabetes: Emerging Findings
Sarah M. Markowitz et al.
PSYCHOSOMATICS (2011)
Using Administrative Data to Identify Mental Illness: What Approach Is Best?
Susan M. Frayne et al.
AMERICAN JOURNAL OF MEDICAL QUALITY (2010)
Duloxetine treatment and glycemic controls in patients with diagnoses other than diabetic peripheral neuropathic pain: a meta-analysis
Antonio Crucitti et al.
CURRENT MEDICAL RESEARCH AND OPINION (2010)
Effect of interventions for major depressive disorder and significant depressive symptoms in patients with diabetes mellitus: a systematic review and meta-analysis
Christina M. Van der Feltz-Cornelis et al.
GENERAL HOSPITAL PSYCHIATRY (2010)
Glycated Hemoglobin, Diabetes, and Cardiovascular Risk in Nondiabetic Adults.
Elizabeth Selvin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Treatment of depression in diabetes: an update
Frank Petrak et al.
CURRENT OPINION IN PSYCHIATRY (2009)
Longitudinal Analysis of Depressive Symptoms and Glycemic Control in Type 2 Diabetes
James E. Aikens et al.
DIABETES CARE (2009)
Effect of Pharmacological Treatment of Depression on A1C and Quality of Life in Low-Income Hispanics and African Americans With Diabetes A randomized, double-blind, placebo-controlled trial
Diana Echeverry et al.
DIABETES CARE (2009)
Quality of life and metabolic status in mildly depressed patients with type 2 diabetes treated with paroxetine:: A double-blind randomised placebo controlled 6-month trial
Maria Paile-Hyvarinen et al.
BMC FAMILY PRACTICE (2007)
Factors influencing glycemic control in type 2 diabetes during acute- and maintenance-phase treatment of major depressive disorder with bupropion
Patrick J. Lustman et al.
DIABETES CARE (2007)
Improved insulin sensitivity in 80 nondiabetic patients with MDD after clinical remission in a double-blind, randomized trial of amitriptyline and paroxetine
Bettina Weber-Hamann et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Are claims data accurate enough to identify patients for performance measures or quality improvement? The case of diabetes, heart disease, and depression
Leif I. Solberg et al.
AMERICAN JOURNAL OF MEDICAL QUALITY (2006)
Depressive symptoms and mortality among persons with and without diabetes
XP Zhang et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2005)
Does antidepressant adherence have an effect on glycemic control among diabetic antidepressant users?
KZ Bambauer
INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE (2004)
Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes
SA Black et al.
DIABETES CARE (2003)
The prevalence of comorbid depression in adults with diabetes - A meta-analysis
RJ Anderson et al.
DIABETES CARE (2001)
Fluoxetine for depression in diabetes - A randomized double-blind placebo-controlled trial
PJ Lustman et al.
DIABETES CARE (2000)
Share Paper
